List of insiders holdings for BiomX Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Yeganeh Reuven Director 10% Owner | 2026-03-18 17:47:41 | 0 3,701,060 | 3,701,060 | Form 4 |
| 2 | Walton Thomas Layton 10% Owner | 2022-02-14 16:24:48 | 0 3,637,846 | 3,637,846 | Form 4 |
| 3 | Cystic Fibrosis Foundation 10% Owner | 2025-03-04 17:34:57 | 2,494,110 0 | 2,494,110 | Form 13G |
| 4 | PROPPER KERRY Mountain Wood LLC 10% Owner | 2020-07-22 19:42:10 | 1,110,209 999,058 | 2,109,267 | Form 4 |
| 5 | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 2026-02-11 19:24:32 | 989,056 0 | 989,056 | Form 13D |
| 6 | Flynn James E Deerfield Mgmt HIF II L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Healthcare Innovations Fund II L.P. Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Director by Deputization Director | 2026-02-11 19:24:32 | 989,056 0 | 989,056 | Form 13D |
| 7 | Solomon Jonathan Eitan Chief Executive Officer | 2025-04-21 08:09:29 | 507,248 0 | 507,248 | Form 4/A |
| 8 | OrbiMed Israel BioFund GP Limited Partnership OrbiMed Israel GP Ltd. GORDON CARL L Chimovits Erez 10% Owner | 2025-06-23 17:08:50 | 276,150 0 | 276,150 | Form 13D |
| 9 | Bassan Merav Chief Development Officer | 2025-04-21 08:11:31 | 174,597 0 | 174,597 | Form 4/A |
| 10 | Wolfson Marina Chief Financial Officer | 2025-04-21 07:44:33 | 163,545 0 | 163,545 | Form 4/A |
| 11 | Gahali-Sass Inbar VP of Platform Research&Devel. | 2019-11-07 18:18:30 | 85,497 0 | 85,497 | Form 3 |
| 12 | Golembo Myriam Vice President of Development | 2019-11-07 18:19:12 | 75,999 0 | 75,999 | Form 3 |
| 13 | Puttagunta Sailaja Chief Medical Officer | 2021-04-01 16:42:48 | 71,250 0 | 71,250 | Form 4 |
| 14 | Sullivan Lynne Marie Director | 2023-03-03 16:01:20 | 41,000 0 | 41,000 | Form 4 |
| 15 | Marks Jason M. Director | 2023-08-23 16:01:16 | 41,000 0 | 41,000 | Form 4 |
| 16 | Dambach Michael E. Director | 2023-08-23 16:01:14 | 41,000 0 | 41,000 | Form 4 |
| 17 | Greig Russell Director | 2025-04-21 07:46:34 | 35,200 0 | 35,200 | Form 4/A |
| 18 | Oron Assaf Chief Business Officer | 2024-09-18 16:01:11 | 25,804 0 | 25,804 | Form 4 |
| 19 | SEKHRI PAUL J Director | 2021-07-30 09:49:09 | 21,875 0 | 21,875 | Form 4 |
| 20 | Amusa Gbolahan Director | 2022-03-31 17:21:23 | 20,500 0 | 20,500 | Form 4 |
| 21 | GROSSMAN JONAS Director | 2022-03-31 17:23:26 | 20,500 0 | 20,500 | Form 4 |
| 22 | Merril Gregory Louis Director | 2025-04-21 08:24:29 | 17,600 0 | 17,600 | Form 4/A |
| 23 | GOODMAN JESSE Director | 2025-04-21 08:07:44 | 17,600 0 | 17,600 | Form 4/A |
| 24 | Williams Eddie Director | 2025-04-21 08:06:04 | 17,600 0 | 17,600 | Form 4/A |
| 25 | Moses Alan Charles Director | 2025-04-21 08:03:02 | 17,600 0 | 17,600 | Form 4/A |
| 26 | LEFF JONATHAN S Director | 2025-04-21 08:00:35 | 17,600 0 | 17,600 | Form 4/A |
| 27 | Blum Susan Director | 2025-04-21 07:57:23 | 17,600 0 | 17,600 | Form 4/A |
| 28 | Breski Yaron Director | 2020-03-27 16:00:43 | 16,000 0 | 16,000 | Form 4 |
| 29 | Giroux Richard Director | 2018-12-14 15:22:26 | 7,500 0 | 7,500 | Form 3 |
| 30 | Kusseluk Eric Director | 2018-12-14 15:24:10 | 7,500 0 | 7,500 | Form 3 |
| 31 | Rossen Matthew Director | 2018-12-14 15:27:20 | 7,500 0 | 7,500 | Form 3 |
| 32 | RICE YEHUDA MICHAEL Director | 2018-12-14 15:27:59 | 7,500 0 | 7,500 | Form 3 |
| 33 | Gnedy Elliot Director | 2018-12-21 12:31:52 | 7,500 0 | 7,500 | Form 3 |
| 34 | MMCAP International Inc. SPC 10% Owner | 2024-02-13 13:09:20 | 0 0 | 0 | Form 13G |
| 35 | TAKEDA PHARMACEUTICAL CO LTD Takeda Ventures Inc. 10% Owner | 2022-08-04 19:59:39 | 0 0 | 0 | Form 13G |
| 36 | Gabay Avraham Interim CFO | 2023-12-11 16:45:38 | 0 0 | 0 | Form 3 |
| 37 | Woodman Robbie Director | 2019-11-07 18:15:56 | 0 0 | 0 | Form 3 |
| 38 | Kaufman George CFO & HOS & Director | 2018-12-14 15:26:41 | 0 0 | 0 | Form 3 |
| 39 | Ben-Or Uri Director | 2019-11-08 14:58:59 | 0 0 | 0 | Form 3 |
| 40 | Chardan Investments LLC 10% Owner | 2019-02-12 19:33:24 | 0 0 | 0 | Form 13G |
| 41 | Bidas Liat Cohavi Director | 2026-03-03 21:27:51 | 0 0 | 0 | Form 3 |
| 42 | Ugwumba Chidozie Exit Form 4 - former 10% owner | 2023-02-13 15:57:09 | 0 0 | 0 | Form 13G |